Denmark · Delayed Price · Currency is DKK Trifork Group AG Earnings Call Transcripts
Fiscal Year 2026
-
Q1 2026 delivered 8% organic growth and 27% EBITDA growth, driven by a product-led strategy and strong public sector wins. Product revenue rose to 45% of total, with margins improving and guidance maintained for 7%-11% organic growth for the year.
Fiscal Year 2025
-
Record revenue of EUR 221 million in 2025 with 7% organic growth and strong Q4 margin improvement. Product revenue rose to 35% of total, driven by demand for AI and data solutions. 2026 guidance targets EUR 230–240 million revenue and further margin gains.
-
Q3 saw 25% growth in platforms and products, strong public sector wins, and improved margins. Full-year revenue is set to break records, with EBITDA close to historic highs and cost savings fully realized in Q4.
-
Revenue grew 5.1% in Q2 and 9.5% for H1 2025, with strong Run segment growth offsetting declines in Build and Inspire. Full-year guidance is maintained, with H2 expected to deliver higher revenue and margins through cost savings and pipeline conversion.
-
Q1 2025 saw record revenue with 14.1% growth, driven by a shift to product-led, recurring revenue and strong public sector wins. Margins are set to improve in H2 as cost savings take effect, and guidance is maintained despite macro risks.
Fiscal Year 2024
-
2024 delivered modest growth with Q4 recovery, driven by strong U.S. performance and a shift to product-led business. 2025 guidance targets 10%-15% growth, supported by cost-saving measures and a robust pipeline. Labs and Run segments showed strong profitability.
-
Revenue and EBITDA for 2024 are expected to be flat or lower than 2023, with significant cost-saving measures underway. Growth is driven by U.S. and public sector contracts, while automotive and construction remain weak. A one-off gain is possible from cyber business deconsolidation.
-
Q2 2024 saw a 7% organic revenue decline and lower EBITDA, prompting a guidance cut to 5% growth and a 14.1-15.8% margin. Public sector wins and Labs growth support a positive outlook for 2025-2027, while cyber protection remains a drag.